CV Event Prediction, Risk Assessment in Type 2 Diabetes
The risk assessment method used in the SAVOR-53 TIMI trial provided a “practical, well-calibrated risk prediction tool.”
HbA1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes and appears to be more powerful than average HbA1c in predicting all-cause death.
Researchers examined the choroidal layer thickness in eyes of patients with diabetes to compare the findings based on medical history of systemic diabetes treatments and stage of diabetic retinopathy.
Family and friends' autonomy support may lead to better glycemic control by reducing distress among patients with diabetes.